Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Terumo Corporation, a leading name in the medical, precision, and optical instruments industry, is headquartered in Japan. Founded in 1921, the company has established a strong presence in major operational regions, including Europe, Asia, and the Americas. Terumo is renowned for its innovative medical devices, blood management systems, and cardiovascular products, which are designed to enhance patient care and improve clinical outcomes.
With a commitment to quality and precision, Terumo has achieved significant milestones, including advancements in minimally invasive technologies. The company is recognised for its unique offerings, such as the world-class syringe and catheter systems, which set industry standards. As a trusted partner in healthcare, Terumo continues to solidify its market position through ongoing research and development, making it a pivotal player in the global medical landscape.
+32 vs industry average
Terumo’s score of 64 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has above-average carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
Terumo, headquartered in Japan and operating in the Medical, precision and optical instruments, watches and clocks industry, reported total global greenhouse gas emissions of approximately 1.577 billion kg CO2e in 2024. This includes about 62 million kg CO2e from Scope 1 emissions, 133 million kg CO2e from Scope 2 emissions, and 1.382 billion kg CO2e from Scope 3 emissions. The Scope 3 emissions breakdown reveals significant contributions from purchased goods and services (approximately 797.734 million kg CO2e), capital goods (about 216.576 million kg CO2e), and end-of-life treatment of sold products (approximately 170.231 million kg CO2e).
Looking back, Terumo's Scope 1 and 2 emissions were approximately 206 million kg CO2e in 2023, 220 million kg CO2e in 2022, and 258 million kg CO2e in 2021.
Terumo has set several ambitious climate commitments. The company is committed to achieving carbon neutrality by FY2040. In line with Science Based Targets initiative (SBTi) commitments, Terumo aims to reduce absolute Scope 1 and 2 GHG emissions by 50.4% by 2030 from a 2018 base year. Furthermore, the company pledges to reduce Scope 3 GHG emissions by 60% per unit of revenue over the same timeframe. These near-term targets for Scope 1 and 2 are classified as consistent with reductions required to keep warming to 1.5°C.
2030
50.4% reduction in Scope 2
Terumo Corporation commits to reduce absolute scope 2 GHG emissions 50.4% by 2030 from a 2018 base year.
2030
50.4% reduction in Scope 1
Terumo Corporation commits to reduce absolute scope 1 GHG emissions 50.4% by 2030 from a 2018 base year.
2030
60% reduction in scope 3 total
Terumo Corporation commits to reduce scope 3 GHG emissions 60% per unit of revenue over the same timeframe.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Terumo’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more